Cargando…
Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity
Elucidating how cannabinoids affect brain function is instrumental for the development of therapeutic tools aiming to mitigate ‘on target’ side effects of cannabinoid‐based therapies. A single treatment with the cannabinoid receptor agonist, WIN 55,212‐2, disrupts recognition memory in mice. Here, w...
Autores principales: | Mouro, Francisco M., Ribeiro, Joaquim A., Sebastião, Ana M., Dawson, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220860/ https://www.ncbi.nlm.nih.gov/pubmed/29989183 http://dx.doi.org/10.1111/jnc.14549 |
Ejemplares similares
-
From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome?
por: Mouro, Francisco Melo, et al.
Publicado: (2019) -
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
por: Rodrigues, Rui S., et al.
Publicado: (2019) -
Cannabinoid agonist rescues learning and memory after a traumatic brain injury
por: Arain, Marium, et al.
Publicado: (2015) -
Adenosine A(2A) receptors facilitate synaptic NMDA currents in CA1 pyramidal neurons
por: Mouro, Francisco M, et al.
Publicado: (2018) -
Brain-Derived Neurotrophic Factor (BDNF) Role in Cannabinoid-Mediated Neurogenesis
por: Ferreira, Filipa Fiel, et al.
Publicado: (2018)